We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Upgraded Hydrogel Stimulates Growth of New Blood Vessels for Tissue Regeneration

By LabMedica International staff writers
Posted on 03 Feb 2015
An upgraded hydrogel for in vivo use as scaffolding for cellular growth incorporates features that overcome most of the limitations that has precluded use of this type of material up to now.

Major limitations of current tissue regeneration approaches using artificial scaffolds are (1) fibrous encapsulation, (2) lack of host cellular infiltration, (3) unwanted immune responses, (4) surface degradation preceding biointegration, and (5) artificial degradation byproducts. More...
Specifically, for scaffolds larger than 200–500 micrometers, implants must be accompanied by generation of new blood vessels by the host (angiogenesis) in order to provide adequate nutrient/waste exchange in the newly forming tissue.

Investigators at Rice University (Houston, TX, USA) reported in the January 13, 2015, online edition of the journal ACS Nano that they had designed a peptide-based self-assembling nano-fibrous hydrogel containing cell-mediated degradation and pro-angiogenic constituents that specifically addressed the limitations of earlier hydrogels. This hydrogel could be easily delivered by syringe, was rapidly infiltrated by cells of hematopoietic and mesenchymal origin, and rapidly formed an extremely robust mature vascular network. Scaffolds showed no signs of fibrous encapsulation and after three weeks were resorbed into the native tissue.

"Implanted synthetic materials tended to become encapsulated by fibrous barriers that kept cells and blood vessels from infiltrating the scaffold," said senior author Dr. Jeffrey Hartgerink, professor of chemistry at Rice University. "That is an extremely common problem in synthetic materials put into the body. Some avoid this problem but if the body does not like a material and is not able to destroy it, the solution is to wall it off. As soon as that happens, the flow of nutrients across that barrier decreases to almost nothing. So the fact that we have developed syringe-directed delivery of a material that does not develop fibrous encapsulation is really important."

"One thing that differentiates our work is the quality of the blood vessels that are formed," said Dr. Hartgerink. "In a lot of the published literature, you see rings that only have the endothelial cell lining, and that indicates a very immature blood vessel. These types of vessels usually do not persist, and disappear shortly after they show up. In ours, you see that same endothelial cell layer, but surrounding it is a smooth muscle cell layer that indicates a much more mature vessel that is likely to persist. There are a lot of features about this hydrogel that come together to make it a unique system. If you look through the literature at what other people have done, each concept that is involved in our system probably exists somewhere already. The difference is that we have all these features in one place working together."

Related Links:

Rice University 



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Staining Management Software
DakoLink
New
Automated Microscope
dIFine
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.